RELATED STUDY
From Cannabis sativa to Cannabidiol: Promising Therapeutic Candidate for the Treatment of Neurodegenerative Diseases
Key Findings: CBD, which interacts with the eCB system, but has also cannabinoid receptor-independent mechanism, might be a good candidate as a prototype for anti-oxidant drug development for the major neurodegenerative disorders, such as PD and AD.
Type of Study: Meta-analysis
Study Result: Positive
Study Location(s): Italy, Poland
Year of Pub: 2020
Cannabinoids Studied: Cannabidiol (CBD)
Phytocannabinoid Source: Not Applicable
Chemotype: Chemotype III
Sub-Ratio: 0:1 (THC:CBD)